The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal revisited.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 27727449.
- Also identified by DOI 10.1002/cncr.30266 and PMC identifier 5161595.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A recent review in this Journal, which criticizes NCCN’s recommendations based, in part, on the RTOG 9501 and the EORTC 22931 trials, warrants comment. We herein provide additional data addressing many of the points and misinterpretations raised in that review which convincingly supports the use of concomitant chemotherapy and radiotherapy in patients with good performance status and high-risk pathologic features after surgery for mucosal head and neck squamous cell carcinoma.
Medical subject headings
- Chemoradiotherapy
- Oropharyngeal Neoplasms